Sort
64,565 grants matching “drug discovery”
Metabolomics of cGVHD
$594,184Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2022 · HL
Core C Pharmacology
$594,171Veronique Dartois · Hackensack University Medical Center · U19 · FY2019 · AI
HIV Gag lattice morphology and particle biogenesis
$594,114Louis M Mansky · University Of Minnesota · R01 · FY2017 · GM
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
$594,099Bruce K Tan · Northwestern University At Chicago · R01 · FY2022 · DC
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
$594,099Bruce K Tan · Northwestern University At Chicago · R01 · FY2021 · DC
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$594,035Afshin Dowlati · Case Western Reserve University · U01 · FY2012 · CA
Epigenetic Marks of Cocaine Addiction
$594,006Deborah C. Mash · University Of Miami School Of Medicine · R01 · FY2015 · DA
"Multispectral Plasmonic Interferometry: A New Tool for High-throughput, Real-time Detection of Cytokines"
$593,999Domenico Pacifici · Brown University · · FY2012 · ENG
Comprehensive Prostate Cancer Characterization by Genomic and Transcriptomic Prof
$593,977Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · CA
A comprehensive thermodynamic and structural characterization of ion channel function and its regulation by the lipid bilayer composition
$593,975Luis Gonzalo Cuello · Texas Tech University Health Scis Center · R35 · FY2023 · GM
RECOVERY OF OPTICAL ABSORPTION COEFFICIENT IN QUANTITATIVE PHOTOACOUSTIC IMAGING
$593,968Lihong Wang · Washington University · R01 · FY2009 · EB
mRNA Splicing Modulation in Familial Dysautonomia
$593,966Susan A Slaugenhaupt · Massachusetts General Hospital · R37 · FY2018 · NS
mRNA Splicing Modulation in Familial Dysautonomia
$593,966Susan A Slaugenhaupt · Massachusetts General Hospital · R37 · FY2017 · NS
Fluorescence lifetime platform to discover small-molecule inhibitors of tau and alpha-synuclein oligomerization.
$593,889Jennifer Jewell Thomas · Photonic Pharma, Llc · R43 · FY2019 · AG
UNS: New Approaches to Catalyst Screening and Development
$593,872David B Berkowitz · University Of Nebraska-Lincoln · · FY2015 · MPS
Mechanistic characterization of JNK2α variants in alcohol-caused heart failure
$593,803Xun Ai · Ohio State University · R01 · FY2025 · AA
Molecular Pathways of Pain Generation in Osteoarthritis
$593,780Anne-Marie Malfait · Rush University Medical Center · R01 · FY2023 · AR
A NOVEL cAMP ASSAY FOR G PROTEIN-COUPLED RECEPTORS
$593,726Anaspec, Inc. · R44 · FY2004 · NS
Imaging of Neuropsychiatric Disorders with Developmental and Genetic Mechanisms
$593,625Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2011 · MH
Waters Desorption Electrospray (DESI) XS TQ Absolute imaging mass spectrometry system
$593,598Brendan Prideaux · University Of Texas Med Br Galveston · S10 · FY2025 · OD
Discovery and optimization of antifungal acetyl CoA synthetase inhibitors
$593,558Damian J Krysan · University Of Iowa · R01 · FY2022 · AI
Genetics of extracellular matrix in health and disease
$593,524Zsolt Urban · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL
HIV Gag lattice morphology and particle biogenesis
$593,325Louis M Mansky · University Of Minnesota · R01 · FY2018 · GM
Synergistic effects of ECM and heterotypic crosstalk on cellular responses in non-alcoholic fatty liver disease
$593,310Salman R Khetani · University Of Illinois At Chicago · R01 · FY2023 · DK
HTS and Proteomics
$593,284Julian P Whitelegge · University Of California Los Angeles · U19 · FY2012 · AI